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Abstract
Background: Art v 1, Amb a 4, and Par h 1 are allergenic defensin-polyproline–
linked proteins present in mugwort, ragweed, and feverfew pollen, respectively. We
aimed to investigate the physicochemical and immunological features underlying the
different allergenic capacities of those allergens.
Methods: Recombinant defensin-polyproline–linked proteins were expressed in
E. coli and physicochemically characterized in detail regarding identity, secondary
structure, and aggregation status. Allergenic activity was assessed by mediator
releases assay, serum IgE reactivity, and IgE inhibition ELISA using sera of
patients from Austria, Canada, and Korea. Endolysosomal protein degradation and
T-cell cross-reactivity were studied in vitro.
Results: Despite variations in the proline-rich region, similar secondary structure
elements were observed in the defensin-like domains. Seventy-four percent and
52% of the Austrian and Canadian patients reacted to all three allergens, while Kor-
ean patients were almost exclusively sensitized to Art v 1. This was reflected by IgE
inhibition assays demonstrating high cross-reactivity for Austrian, medium for Cana-
dian, and low for Korean sera. In a subgroup of patients, IgE reactivity toward struc-
turally altered Amb a 4 and Par h 1 was not changed suggesting involvement of
linear epitopes. Immunologically relevant endolysosomal stability of the defensin-like
domain was limited to Art v 1 and no T-cell cross-reactivity with Art v 125-36 was
observed.
Conclusions: Despite structural similarity, different IgE-binding profiles and
proteolytic processing impacted the allergenic capacity of defensin-polyproline–
linked molecules. Based on the fact that Amb a 4 demonstrated distinct IgE-binding
epitopes, we suggest inclusion in molecule-based allergy diagnosis.
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1 | INTRODUCTION
Allergy to weed pollen has been extensively documented worldwide,
being the third most important cause of pollen allergies, after grasses
and trees. Relevant allergenic weeds of the Asteraceae family are mug-
wort (Artemisia vulgaris), ragweed (Ambrosia artemisiifolia), Santa Maria
feverfew (Parthenium hysterophorus), and sunflower (Helianthus
annuus).1 Mugwort and ragweed are preferentially growing in the
temperate climate zone of the Northern Hemisphere and Australia,
while feverfew grows in the subtropical areas of America and Asia. In
Europe, exposure to mugwort pollen is more abundant in central and
northern regions, ragweed in south and eastern areas, while feverfew
is not endemic (www.pollenwarndienst.at). In northern America, rag-
weed represents the most prevalent Asteraceae pollen source, while
in Korea exposure to mugwort and ragweed is observed.2,3 Atypical
distribution and intensified flowering seasons of weeds are anticipated
which potentially lead to more allergic reactions as a consequence of
climatic changes.4-6
Extract-based allergy diagnosis of weed pollen is frequently
challenging due to (i) polysensitization of patients, (ii) overlapping
flowering periods, and (iii) similar allergen profiles.7,8 Although
molecule-based approaches can be exploited for diagnosis, solely
Amb a 1, Art v 1, and Art v 3 are currently available for routine
allergy diagnosis of Asteraceae pollen allergy.2 Several studies
showed that sensitization profiles to distinct allergens from the
same weed are highly diverse in different geographic regions.4,7,9,10
Even molecules from the same protein family like lipid transfer pro-
teins (LTP) or pectate lyases can show different sensitization poten-
cies, and in this context, allergenic defensin-like proteins linked to
a polyproline-rich region are interesting molecules. Those defensin-
polyproline–linked proteins are exclusively found in pollen of the
Asteraceae family, while defensin-like proteins alone are prevalent
in higher plants and were recently also described as allergens in
legumes.1,11,12
Art v 1 is a major allergen with a sensitization rate of 95% among
mugwort pollen-allergic patients.13 Amb a 4, the homolog in ragweed,
is considered a minor allergen with 20%-40% sensitization rate among
ragweed-allergic patients.14 Recently, the complete sequence of Par h
1 from feverfew was identified and a sensitization rate of 60% and
40% among Austrian and Indian pollen-allergic patients was reported.15
A common feature of this allergen family is O-linked glycosylation of
hydroxyproline residues.13,14,16,17 Despite the fact that low levels of
IgE antibodies against glycan moieties of Art v 1 were detected, they
did not convey mediator release and thus demonstrated low clinical sig-
nificance.18 If O-linked glycans contribute to unspecific cross-reactivity
in diagnosis remains to be determined. While structural and immuno-
logical features of Art v 1 have been extensively investigated,13,16,19,20
only limited information is available for Amb a 4 and Par h 1.14,15
In the present study, we investigated structural and immunologi-
cal features of allergenic defensin-polyproline–linked molecules from
mugwort, ragweed, and feverfew pollen. Therefore, recombinant
allergens were produced to evaluate intrinsic physicochemical char-
acteristics. IgE sensitization profiles and cross-reactivity pattern were
investigated in patients from three geographically distinct regions.
Endolysosomal degradation assays were performed to monitor prote-
olytic susceptibility, and T-cell assays were conducted to analyze
cross-reactivity at the T-cell level.
2 | METHODS
Detailed description of all experimental procedures is provided in
the Data S1.
2.1 | Patients and sera
Weed pollen-allergic patients from Austria (n = 36), Canada (n = 38),
and Korea (n = 24) were selected on the basis of typical case
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history, that is, rhinitis and/or conjunctivitis during late summer, and
allergen-specific IgE to mugwort and/or ragweed pollen determined
by ImmunoCAP or skin prick test (Table S1). Experiments using
anonymized serum samples from allergic patients were approved by
the Ethics Committee of the Medical University of Vienna, Austria
(No. 712/2010), the IRB—Institutional Review Board Services, Aur-
ora, Ontario, Canada, and the Institutional Review Board of the
Yonsei University Health System, Seoul, Korea (No. 4-2013-0397).
Informed written consents were obtained from all individuals.
2.2 | In silico analysis, protein expression, and
purification
In silico analysis of the defensin-like domain was performed with
Clustal Omega, SWISS-MODEL, and Chimera 1.8. Constructs corre-
sponding to the mature sequences of Art v 1.0101, Amb a 4.0101,
and Par h 1.0101 were cloned into the pHis Parallel 2 expression
vector.13,15 Protein expression of nontagged proteins was performed
in E. coli Rosetta-gamiB (DE3) pLysS as described.15 Briefly, Art v 1
was obtained by ultrafiltration followed by cation exchange and size
exclusion chromatography. Amb a 4 and Par h 1 were purified using
ammonium sulfate precipitation followed by hydrophobic interaction
and size exclusion chromatography.
2.3 | Physicochemical characterization
Purified allergens were analyzed by reducing SDS-PAGE and Coo-
massie staining. Protein concentrations were determined by amino
acid analysis, and identity was verified by intact mass analyses using
a Q-Exactive mass spectrometer. The aggregation behavior of the
proteins was analyzed by dynamic light scattering (DLS) and high-
performance liquid chromatography (HPLC). Secondary structure ele-
ments were determined by Fourier transform infrared (FTIR) spec-
troscopy using a Tensor 27 spectrophotometer. Circular dichroism
spectra of native and heat-treated proteins were recorded with a
JASCO J-815 spectropolarimeter.
2.4 | IgE reactivity, cross-inhibition, and mediator
release assay
IgE reactivity of weed pollen extracts and purified allergens was evalu-
ated by ELISA using sera from weed pollen-allergic patients. The biolog-
ical activity of the allergens was verified in a mediator release assay.21
Detection of IgE reactivity to purified allergens was performed using a
colorimetric ELISA. IgE reactivity to reduced/alkylated (R/A) allergens
was assessed using a chemiluminescence ELISA. IgE cross-reactivity
between purified allergens was studied by cross-inhibition ELISA. Sera
were pre-incubated overnight with the inhibitor molecules or buffer.
2.5 | Proteolytic stability
The proteolytic stability was studied with the endolysosomal
degradation assays.22 Recombinant allergens were incubated with
the microsomal fraction of a murine dendritic cell (DC) line or puri-
fied recombinant cathepsin S. Samples were analyzed at differ-
ent time points using gel electrophoresis and mass spectrometry.
2.6 | T-cell reactivity
Monocyte-derived dendritic cells were differentiated as
described23,24 and incubated with the allergens or Art v 1-peptide.
Art v 125-36-specific TCR tg Jurkat T-cells
25,26 were added and
cocultured and IL-2 promoter-driven luciferase activity was deter-
mined.25 Art v 125-36-specific T-cell lines and clones established
from mugwort-allergic donors were tested for proliferation in
response to the allergens or Art v 1-peptide by 3H-thymidine
uptake.20
2.7 | Data processing and statistical analyses
An unsupervised cluster analysis was performed with ClustVis using
IgE reactivity and cross-inhibition data.27 Statistical analyses were
performed in GraphPad Prism using a Friedman test for nonparamet-
ric analyses followed by a Dunn’s multiple comparison and Spear-
man’s correlation tests.
3 | RESULTS
3.1 | Homologous allergens present typical features
of defensin-polyproline–linked proteins
To investigate the physicochemical and structural features of Art v 1,
Amb a 4, and Par h 1, the allergens were expressed as nontagged pro-
teins in E. coli. They shared the prototypical features of defensin-
polyproline–linked proteins with an N-terminal defensin-like domain
and eight conserved cysteine residues.19 Sequence identities ranging
from 67% to 78% in the defensin-like domain were noted (Figure 1A).
A common feature in the C-terminal region is the high proline content,
while there are major differences in length and amino acid composi-
tion. The proline-rich regions of Amb a 4 and Par h 1 are longer and
contain substantially more glycine residues. The high content of acidic
amino acids in this region renders Amb a 4 and Par h 1 acidic in con-
trast to Art v 1. The structural models generated using Art v 1 as tem-
plate revealed partially conserved IgE-binding epitopes of the
homologs (Figure 1B, Fig. S1). The proline-rich region could not be
modeled due to low sequence similarity and high flexibility.19
All three allergens were purified to homogeneity with purities of
>98% (Fig. S2A). In line with previous results, they showed an unu-
sual electrophoretic behavior.13-15 The protein identity and formation
of four disulfide bonds were unequivocally verified by mass spec-
trometry (Fig. S2B). Protein preparations were monomeric with a Rh
~2 nm as assessed by DLS, and in HPLC, they eluted as single peaks
with comparable retention times and molecular weight (Fig. S2C,D).
FTIR analysis revealed the presence of defined secondary structure
elements. Consistent with the structure of Art v 1, the proteins
showed a higher content of beta sheets than alpha helices, and the
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amount of disordered structures positively correlated with the length
of the proline-rich region (Figure 1C and Fig. S3A). In CD analyses,
almost identical spectra were recorded, indicating a similar folding
consistent with proline-rich proteins (Figure 1D).13,15,21 The defen-
sin-polyproline–linked proteins exhibited comparable stability to ther-
mal denaturation, and structural changes observed at 222 nm were
analogous. However, denaturation spectra of Amb a 4 and Par h 1
shared higher similarity compared to Art v 1 (Fig. S3B).
3.2 | Weed pollen-allergic patients from different
geographic regions demonstrate distinct sensitization
profiles
To assess the immunological relevance, we investigated sera of weed
pollen-allergic patients from Austria, Canada, and Korea. First, we
evaluated the patients’ sensitization profile to pollen extracts of
mugwort, ragweed, and feverfew in ELISA (Figure 2A,B). The major-
ity of Austrian patients were multisensitized to all three sources,
with ragweed presenting strongest IgE binding followed by mugwort
pollen. While 53% of the Canadian patients reacted to ragweed as
well as mugwort, a strong bias toward ragweed sensitization was
noted which was also reflected by significantly higher IgE levels. The
Korean patients showed a dominant mugwort sensitization profile
with 58% mono-sensitized patients.
The allergenic activity of all recombinant allergen preparations
was verified in a mediator release assay (Fig. S4), and IgE reactivity
of individual sera was monitored in ELISA (Figure 2C,D, Table S1).
Sensitization to any of the tested molecules was detected in 19/36,
21/38, and 22/24 of the Austrian, Canadian, and Korean patients,
respectively. Seventy-four percent of patients from Austria and 52%
from Canada who reacted to one of the tested allergens were also
positive for the homologous molecules with similar IgE levels. Con-
versely, most Korean patients were exclusively sensitized to Art v 1,
which is also reflected by significantly higher IgE levels. Of note,
highly correlating IgE levels were observed between Amb a 4 and
Par h 1, while correlations with Art v 1 were lower especially among
Korean patients (Fig. S5).
3.3 | Defensin-polyproline–linked allergens
demonstrate varying degrees of IgE cross-reactivity
In order to test the IgE cross-reactivity, we performed an ELISA inhi-
bition study with reactive patients’ sera (Figure 3). When Art v 1
was immobilized, Amb a 4 and Par h 1 were cross-inhibiting with a
mean of 50% and 46% in the Austrian patients, respectively. Among
Canadian patients, similar results were observed although Amb a 4
was slightly more potent than Par h 1, but statistically not signifi-
cant. Low cross-inhibition potential was observed among Korean
patients, where Amb a 4 and Par h 1 showed only 19% and 15%
cross-reactivity with Art v 1, respectively. Generally, sera from Aus-
trian patients demonstrated broader IgE cross-reactivity with Art v 1
in comparison with Korean patients where cross-inhibition was
restricted to only few patients. Inhibition to immobilized Amb a 4
ranged from 41% to 55% in the Austrian and Korean patients, while
mean inhibition was <30% in Canadian patients’ sera. When Par h 1
was immobilized, we observed a similar inhibitory capacity of Amb a
4 and Par h 1, with Amb a 4 inhibition even more pronounced in
some Canadian sera. Compared to Amb a 4, Art v 1 proved to be a
weaker inhibitor for Par h 1 which was most prominent in the
Canadian group.
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F IGURE 1 Art v 1, Amb a 4, and Par h 1 are homologous allergens with a defensin-like fold. A, Sequence alignment of the defensin-like
domain and comparison of the proline-rich region. b-sheets and a-helix from Art v 1 sequence are indicated by green arrows and purple
waves, respectively. The lines above the sequence represent disulfide bonds. B, A ribbon side-view representation of the three-dimensional
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3.4 | IgE reactivity is differently affected upon
structural alteration of the defensin-like fold
IgE reactivity of Art v 1 is highly dependent on the cysteine-stabi-
lized defensin-like fold, which prompted us to investigate the sus-
ceptibility of the homologous molecules.13,21 Successful reduction/
alkylation of proteins was verified by mass spectrometry and an
increase of unordered structures was observed in CD and FTIR mea-
surements (Fig. S6). For ELISA analyses, we used a chemilumines-
cence system in order to efficiently monitor changes in IgE binding.
As expected, reduction/alkylation of the defensin-like domain essen-
tially abolished IgE binding to Art v 1 (Figure 4). Interestingly, IgE
reactivity to reduced/alkylated Amb a 4 and Par h 1 showed a differ-
ent profile as several Austrian and Canadian sera still recognized the
structurally altered molecules. The majority of tested sera demon-
strated loss of IgE reactivity, while others were still able to substan-
tially bind to structurally altered Amb a 4 and Par h 1 with similar
efficiency (Fig. S7). On the other hand, IgE reactivity to reduced/
alkylated proteins was diminished for all allergens among Korean
patients. An unsupervised clustering analysis using sera reactive to
all three allergens revealed three patients’ groups (Fig. S8).
3.5 | Defensin-polyproline–linked allergens
demonstrate different susceptibility to endolysosomal
degradation
Using the endolysosomal degradation assay, we analyzed kinetics
and proteolytic degradation pattern by gel electrophoresis and mass
spectrometry, respectively. Proteins were susceptible to cleavage of
the intact protein within 0.5-3 hours (Figure 5A). Degradation of the
proteins yielded proteolytic products with clear differences in
kinetics, with highest stability for a 12-kDa Art v 1 fragment. All pro-
teins underwent an early proteolytic cleavage resulting in separation
of the two domains. Notably, the defensin-like domain of Art v 1
was stable for 72 hours while those of Amb a 4 and Par h 1 were
mostly degraded within 8 and 16 hours, respectively (Figure 5B).
Major differences were observed regarding the proline-rich region;
the C-terminal fragments of Amb a 4 and Par h 1 were detectable
up to 72 hours while Art v 1 was highly susceptible to proteolysis
(Figure 5B). Proteolytic peptides identified by mass spectrometry
supported these findings (Fig. S9). Similar degradation patterns were
found within the conserved defensin-like domain although kinetics
varied considerably (Figure 6). Typically, defensin-like domains were
degraded from both ends to the inner core and generated peptides
were spanning the immunodominant T-cell epitope of Art v 1.20,26
Analogous degradation kinetics and cleavage sites were observed
using cathepsin S (Fig. S10).
These results prompted us to investigate whether the homolo-
gous allergens were cross-reactive at the T-cell level. Therefore, we
used Jurkat T-cells transfected with a TCR specific for the immun-
odominant T-cell epitope of Art v 1 as well as T-cell lines and clones
specific for Art v 1.20,25 Under these experimental conditions, Amb a
4 and Par h 1 did neither demonstrate T-cell cross-reactivity with
the TCR specific for Art v 125-36, nor with Art v 1-specific T-cells
restricted to HLA-DR1 (Fig. S11).
4 | DISCUSSION
Relevant pollen allergens of the Asteraceae family belong to pectate
lyases, defensin-like domain linked to a polyproline region, and lipid
transfer proteins.2,7 With the exception of Art v 1, allergenic
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defensin-polyproline–linked proteins are only scarcely investigated.
While Art v 1 is considered the major allergen of mugwort pollen,13
homologs from ragweed and feverfew are considered minor aller-
gens.14,15 It is believed that distinct IgE sensitization profiles may
arise from varying exposure to weeds in different geographic
regions.7,9 We further investigated whether intrinsic molecular char-
acteristics of defensin-polyproline–linked allergens could also
account for distinct sensitization profiles.
Recombinant allergens showed typical structural features of the
defensin-like protein family while amino acid sequences vastly dif-
fered in the proline-rich region.13-15 Structural modeling showed that
IgE epitopes of Art v 1 are partially conserved in Amb a 4 and Par h
1. The proline-rich region did not allow reliable prediction due to low
sequence similarity and high structural flexibility.19,28 In FTIR, compa-
rable distributions of secondary structure elements were found which
reflected previous NMR data obtained for Art v 1 in solution.19 Over-
all, proteins showed similar spectra in CD measurements and neither
dimerization nor aggregation was identified for any of the protein
batches. Thermal denaturation analyses showed similar unfolding pat-
tern while melting curves of Amb a 4 and Par h 1 were different from
Art v 1 suggesting divergent unfolding paths. Due to the high content
of unordered motifs, interpretation of structural changes relating to
the defensin-like domain has to be made with caution. Tentatively,
the flexible polyproline regions account for different physiological
roles as a consequence of different amino acid content, net charge,
and length.28-30
Next, the sensitization profile to weed pollen was investigated
in patients from Austria, Canada, and Korea. Patients from Aus-
tria were sensitized to ragweed and mugwort due to the con-
comitant growth of both weeds in this region7,31; only two
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patients were exclusively reactive to ragweed extract. The Cana-
dian patients showed a prevalent sensitization to ragweed,7,31
while 55% were also reactive to mugwort due to either IgE
cosensitization or cross-reactivity.32,33 In contrast, Korean
patients presented genuine sensitization to mugwort, which cor-
responded to the dominant Asteraceae weed sensitization in this
region.34 IgE sensitization profiles to feverfew pollen were
recorded in order to evaluate cross-reactivity in Austrian and
Canadian patients typically not exposed to this weed. Growth of
feverfew has been reported in Southern Korea4 (http://www.cabi.
org/isc/datasheet/45573); however, its implication in allergy has
not been established.
Using recombinant allergens, a dominant IgE reactivity to Art v 1
(92%) among Korean patients was noted. Art v 1 sensitization preva-
lence in Canada and Austria was only 55% and 53%, respectively,
suggesting that those patients were also reactive to Amb a 1.7,31
Notably, Art v 1 and Par h 1 represent the most prevalent molecules
in the pollen extract, while Amb a 4 levels are outperformed by the
major allergen Amb a 1 (unpublished data). Among Austrian patients
sensitized to defensin-polyproline–linked proteins, 73% reacted to all
three allergens in a similar manner with slightly higher IgE reactivity
to Art v 1. The sensitization prevalence of 42% to Amb a 4 was in
agreement with 39% as previously described.14 Comparable results
were obtained for Par h 1 (47%) refining a 40% and 60% prevalence
determined before in a limited group of Indian and Austrian patients,
respectively.15 Two sera showed exclusive reactivity to Par h 1
which may be a consequence of exposure during traveling or living
in countries where feverfew is endemic. Among Austrian patients,
Art v 1 was more dominant at IgE cross-inhibition, suggesting that
most of the patients were primary sensitized to this mugwort aller-
gen.14 Among Canadian patients who demonstrated particularly
lower mugwort than ragweed pollen sensitization, similar but rather
weak IgE levels to all molecules were observed. In this scenario, Art
v 1 showed the same intensity of IgE reactivity as Amb a 4 and Par
h 1, although the sensitization prevalence to Art v 1 was the same
as in the Austrian group (47%). As patients in northern America are
frequently sensitized to ragweed, we could speculate that Amb a 4
acts as primary sensitizer.14,33 This is supported by inhibition ELISA
results, with Amb a 4 being more efficiently inhibiting Art v 1 than
vice versa. An analogous observation has been made for the pectate
lyases Amb a 1 and Art v 6 corroborating that primary sensitization
is highly dependent on weed pollen exposure.33,35 In Korea, Art v 1
showed a dominant IgE reactivity, with only eight patients addition-
ally reacting to the homologous allergens. This result might relate to
strong affinity maturation of IgE antibodies due to continuous mug-
wort pollen exposure.34,36 Notably, Amb a 4 and Par h 1 showed
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Art v 1 Amb a 4 Par h 1 Art v 1 Amb a 4 Par h 1 Art v 1 Amb a 4 Par h 1
*
ns
R
ed
uc
tio
n 
in
Ig
E
 re
ac
tiv
ity
  (
%
)
Reduced/alkylated proteins
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
ns
ns
ns ns ns
ns
ns
F IGURE 4 Amb a 4 and Par h 1 bear IgE epitopes which are not shared with Art v 1. IgE reactivity to native and reduced/alkylated
allergens was evaluated in ELISA and percentage of reduction in IgE reactivity is depicted. Graphs show mean  SEM, *P ≤ .05 and ns, not
significant
(A)
25
15
10
25
15
10
25
15
10
0 0.5 1 3 8 16 24 48 72
hours
kDa
Art v 1
Amb a 4
Par h 1
(B)
Intact protein
Defensin domain
Proline-rich region
Intact protein
Defensin domain
Proline-rich region
Intact protein
Defensin domain
Proline-rich region
0 0.5 1 3 8 16 24 48 72 hours
Art v 1
Amb a 4
Par h 1
F IGURE 5 Defensin-polyproline–linked
allergens present different susceptibility to
endolysosomal degradation using
microsomal fraction of a murine DC line. A,
Time-dependent proteolytic degradation
was monitored by SDS-PAGE and
Coomassie staining. B, Intact mass analysis
was performed by mass spectrometry
PABLOS ET AL. | 437
Art v 1 
A G S K L C E K T S K T Y S G K C D N K K C D K K C I E W E K A Q H G A C H K R E A G K E S C F C Y F D C S K S P P G A
1 2 43 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
G A K L C E K P S V T W S G K C K V K Q T D K C D K R C I E W E G A K H G A C H K R D S K A T C F C Y F D C D P T K N P
1 2 43 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
G K V C E K P S K T W F G N C K D T E K C D K R C M E W E G A K H G A C H Q R E S K Y M C F C Y F D C D P K K N P G P P 
1 2 43 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
8 16 24 48 720 0.5 1 3
hours
Amb a 4
Par h 1 
F IGURE 6 Endolysosomal degradation patterns within the defensin-like domains. Peptide pattern was obtained after incubation of the
allergens with endolysosomal proteins from a murine DC line and analyzed by mass spectrometry. The immunodominant T-cell epitope
Art v 125-36 is boxed with solid lines; homologous regions are boxed with dashed lines
438 | PABLOS ET AL.
low inhibitory capacities in blocking IgE binding to Art v 1 in these
patients. In all patients, IgE reactivity to Par h 1 was virtually the
same as for Amb a 4, also reflected by highly correlating antibody
levels. Even though Par h 1 sensitization has to be considered a
cross-reactivity phenomenon in the investigated context, this might
have implications for patients sensitized to Art v 1 or Amb a 4.
To study reactivity pattern in detail, we investigated whether
reduction and alkylation lead to loss of IgE reactivity. In line with
previous studies, the appropriate folding of the Art v 1 defensin-like
domain was crucial for IgE reactivity.13,21 However, when the folding
of Amb a 4 or Par h 1 was altered, we observed a different trend
among Austrian and Canadian patients. Interestingly, among those
patients where IgE reactivity to Amb a 4 and Par h 1 was less
affected by reduction and alkylation, Art v 1 was worse in inhibiting
the IgE reactivity to these molecules. The observations were con-
firmed by unsupervised clustering analysis considering IgE reactivity,
impairment due to allergen reduction and alkylation, as well as IgE
cross-reactivity of patients sensitized to all three allergens. Results
suggest at least one cross-reactive epitope located in the defensin-
like domain and in fact three amino acids of the IgE-binding epitope
of Art v 1 are conserved in the homologs.19 In this context, Amb a 4
and Par h 1 seem to possess an epitope which is not shared with
Art v 1 and reflects either a linear epitope in the defensin-like
domain or is located in the proline-rich region. Cluster analysis sug-
gested that most of the patients where Art v 1 failed to inhibit IgE
reactivity to Amb a 4 and Par h 1 were from Canada and thus pri-
mary sensitized to ragweed pollen. However, a considerable number
of Austrian patients also demonstrated such a profile indicating pri-
mary sensitization to ragweed in this subgroup.
Several studies showed that protein immunogenicity is linked to
endolysosomal processing during antigen presentation.22,37,38 All
three proteins presented an early cleavage resulting in separation of
the two domains. Subsequent degradation showed divergent profiles
with high stability of the Art v 1 defensin-like domain and proline-
rich region of Amb a 4 and Par h 1. The enhanced stability of the
defensin-like domain might explain the stronger immunogenicity of
Art v 1, and in fact, the immunodominant T-cell epitope is located in
this region.20,39 In contrast, premature degradation and thus subopti-
mal peptide loads resulting in poor presentation on MHC-II might be
a reason for a lower immunogenicity of Amb a 4 and potentially also
Par h 1.14,37,40
As differences in the primary structure might provide distinct
cleavage sites for different proteases, we additionally investigated
the proteolytic stability to cathepsin S, a major component of the
endolysosomal protease cocktail.22,41,42 Similar degradation kinetics
was observed as compared with the endolysosomal extract and, in
general, cathepsin S cleavage sites were conserved (Fig. S11). Poten-
tially, other proteases of the endolysosomal fraction, varying intrinsic
stability, or resistance to redox environment of proteins might
account for minor differences.43-45 Proteolytic peptides typically har-
bored the immunodominant T-cell epitope previously determined for
Art v 1,20 which prompted us to investigate T-cell cross-reactivity.
Despite high sequence similarity in this region, we observed no
T-cell cross-reactivity using Art v 1-specific T-cell assays. Results are
largely in agreement with Jahn-Schmid et al26 who described that
the crucial minimal Art v 1 T-cell epitope (EWEKA) was restricted to
HLA-DR1. It is important to note that our experimental settings
focused on the immunodominant epitope Art v 125-36, while T-cell
cross-reactivity between other, minor epitopes and HLA class II
restrictions other than those by HLA-DR1 was not investi-
gated.20,26,39 However, this finding also implicates that Art v 1 alone
might not be efficient when considering molecule-based
immunotherapy approaches.
In summary, we show that regardless of the structural similarity
shared by the allergenic defensin-polyproline–linked proteins, they
differ in their immunological properties. The higher sensitization rate
of Art v 1 is consistent with the increased stability to proteolytic
degradation, which ensures a steady supply of T-cell epitopes. A
group of patients reacted exclusively to Amb a 4/Par h 1 epitopes
which are not dependent on the cysteine-stabilized fold of the
defensin-like domain. We therefore suggest including Amb a 4 in
molecule-based diagnosis of weed pollen allergies, thus allowing fur-
ther refinement for therapeutics in allergen immunotherapy.
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